Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +6.20% | -31.84% | -57.72% |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Apr. 22 | Sector Update: Health Care | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 18.51 | 70.14 | 86.9 | 22.89 | 14.05 | 7.497 | - | - |
Enterprise Value (EV) 1 | 18.51 | 29.58 | 86.9 | 22.89 | 14.05 | 7.497 | 7.497 | 7.497 |
P/E ratio | -0.9 x | -1.04 x | -2.43 x | -0.51 x | - | -0.13 x | - | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - | - |
EV / EBITDA | - | -3,487,299 x | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 173 | 1,601 | 3,811 | 3,811 | 4,338 | 5,472 | - | - |
Reference price 2 | 107.2 | 43.80 | 22.80 | 6.006 | 3.240 | 1.370 | 1.370 | 1.370 |
Announcement Date | 5/14/20 | 3/31/21 | 4/8/22 | 4/10/23 | 4/16/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | -20.11 | - | - | - | - | - | - |
EBIT 1 | -7.77 | -20.15 | -30.4 | -43.62 | - | -55.32 | -76.09 | -90.5 |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -7.946 | -20.32 | -32.72 | -45.08 | -49.34 | -51.55 | -76.09 | -90.5 |
Net income 1 | -6.719 | -20.36 | -32.72 | -45.34 | -48.93 | -51.55 | -76.09 | -90.5 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -119.0 | -42.00 | -9.400 | -11.80 | - | -10.72 | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 5/14/20 | 3/31/21 | 4/8/22 | 4/10/23 | 4/16/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT | - | -9 | -7.252 | -20 | -8.465 | -7.902 | -13.21 | -14.17 | -10.66 | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | -9.733 | -6.93 | -19.91 | -8.548 | -9.695 | -13.26 | -14.08 | -10.53 | -11.47 | - | - | - | - |
Net income | -9.267 | -9.733 | -6.93 | -19.91 | -8.548 | -9.949 | -13.26 | -14.08 | -10.53 | -11.06 | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 1 | -2.400 | -2.600 | -1.800 | -5.200 | -2.200 | -2.600 | -3.480 | -3.680 | -2.740 | - | -3.600 | -3.710 | -1.900 | -1.970 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 4/8/22 | 5/16/22 | 8/15/22 | 11/14/22 | 4/10/23 | 5/12/23 | 8/14/23 | 11/20/23 | 4/16/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | 40.6 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 5/14/20 | 3/31/21 | 4/8/22 | 4/10/23 | 4/16/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.72% | 7.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HEPA Stock
- Financials Hepion Pharmaceuticals, Inc.